Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1721 (LINC01721)
- Target
- LINC01721
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01
Overview
Long intergenic non-protein coding RNA 1721 (LINC01721) is a long non-coding RNA gene located on human chromosome 20 and belongs to the long intergenic non-coding RNA (lincRNA) family. LincRNAs are defined as noncoding RNA molecules over 200 nucleotides in length that do not overlap protein-coding genes. While the specific functions of LINC01721 remain uncharacterized, lincRNAs as a class participate in diverse processes such as chromatin remodeling, transcriptional regulation, and modulation of gene expression networks, often exhibiting tissue-specific expression and regulatory functions. Unlike protein-coding genes or typical drug targets, LINC01721 does not encode a protein and is not considered a druggable therapeutic target based on current knowledge. Its potential biological roles may be inferred from the broader functions of lincRNAs, but direct evidence for LINC01721 is lacking.
- Other names
- LINC01721
02
Mechanism of action
null
03
Biological functions
The precise function of LINC01721 remains uncharacterizedRegulation of chromatin structure and gene expression (general lincRNA function)RNA stabilization (general lincRNA function)Scaffolding of protein- or RNA complexes (general lincRNA function)Transcriptional regulation, often with tissue specificity (general lincRNA function)Fine-tuning gene expression of neighboring genes (general lincRNA function)
04
Disease associations
OtherNo direct disease association specifically for LINC01721 is documented in current resources as of 2024More broadly, some lincRNAs are known to be involved in cancer, gene regulation disorders, and developmental diseases, but this has not been established for LINC01721 specifically
05
Safety considerations
None specific known. There are no documented safety or toxicology issues or therapeutic challenges reported for LINC01721
06
Interacting drugs
None known. No drugs have been described to specifically target or interact with LINC01721
07
Biomarkers
None known. LINC01721 is not currently reported as a clinical or preclinical biomarker
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1721 (LINC01721).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1721 (LINC01721).